Prosthetic Heart Valve Design and Orientation Dictate Physiological and Non-physiological Flow Patterns in Left Ventricle: An In-vitro Double Valve Replacement Study

2020 ◽  
Vol 4 (sup1) ◽  
pp. 158-160
Author(s):  
Satheesh Kumar H. ◽  
Shailendra D. Sharma
Author(s):  
Hélène A. Simon ◽  
Liang Ge ◽  
Iman Borazjani ◽  
Fotis Sotiropoulos ◽  
Ajit P. Yoganathan

Native heart valves with limited functionality are commonly replaced by prosthetic heart valves. Since the first heart valve replacement in 1960, more than three million valves have been implanted worldwide. The most widely implanted prosthetic heart valve design is currently the bileaflet mechanical heart valve (BMHV), with more than 130,000 implants every year worldwide. However, studies have shown that this valve design can still cause major complications, including hemolysis, platelet activation, and thromboembolic events. Clinical reports and recent in vitro experiments suggest that these thrombogenic complications are associated with the hemodynamic stresses imposed on blood elements by the complex non-physiologic flow induced by the valve, in particular in the hinge region.


1983 ◽  
Vol 105 (3) ◽  
pp. 263-267 ◽  
Author(s):  
W. J. Yang ◽  
J. H. Wang

A numerical model is developed to predict the complex velocity, shear and pressure fields in steady turbulent flow through a disk-type prosthetic heart valve in a constant diameter chamber. The governing Navier-Stokes equations are reduced to a set of simultaneous algebraic finite-difference equations which are solved by a fast-converging line-iterations technique. A two-parameter, two-equation model is employed to determine the turbulent viscosity. Numerical results are obtained for stream function, vorticity, and shear and normal stresses. The regions of very high shear and normal stresses in the fluid and at the walls are identified. The maximum value of the shear stress occurring near the upstream corner of the disk may cause hemolysis. The technique can be used together with in-vitro physcial experiments to evaluate existing or future prosthetic heart valve designs.


2014 ◽  
Vol 136 (12) ◽  
Author(s):  
Sharan Ramaswamy ◽  
Steven M. Boronyak ◽  
Trung Le ◽  
Andrew Holmes ◽  
Fotis Sotiropoulos ◽  
...  

The ability to replicate physiological hemodynamic conditions during in vitro tissue development has been recognized as an important aspect in the development and in vitro assessment of engineered heart valve tissues. Moreover, we have demonstrated that studies aiming to understand mechanical conditioning require separation of the major heart valve deformation loading modes: flow, stretch, and flexure (FSF) (Sacks et al., 2009, "Bioengineering Challenges for Heart Valve Tissue Engineering," Annu. Rev. Biomed. Eng., 11(1), pp. 289–313). To achieve these goals in a novel bioreactor design, we utilized a cylindrical conduit configuration for the conditioning chamber to allow for higher fluid velocities, translating to higher shear stresses on the in situ tissue specimens while retaining laminar flow conditions. Moving boundary computational fluid dynamic (CFD) simulations were performed to predict the flow field under combined cyclic flexure and steady flow (cyclic-flex-flow) states using various combinations of flow rate, and media viscosity. The device was successfully constructed and tested for incubator housing, gas exchange, and sterility. In addition, we performed a pilot experiment using biodegradable polymer scaffolds seeded with bone marrow derived stem cells (BMSCs) at a seeding density of 5 × 106 cells/cm2. The constructs were subjected to combined cyclic flexure (1 Hz frequency) and steady flow (Re = 1376; flow rate of 1.06 l/min (LPM); shear stress in the range of 0–9 dynes/cm2) for 2 weeks to permit physiological shear stress conditions. Assays revealed significantly (P < 0.05) higher amounts of collagen (2051 ± 256 μg/g) at the end of 2 weeks in comparison to similar experiments previously conducted in our laboratory but performed at subphysiological levels of shear stress (<2 dynes/cm2; Engelmayr et al., 2006, "Cyclic Flexure and Laminar Flow Synergistically Accelerate Mesenchymal Stem Cell-Mediated Engineered Tissue Formation: Implications for Engineered Heart Valve Tissues," Biomaterials, 27(36), pp. 6083–6095). The implications of this novel design are that fully coupled or decoupled physiological flow, flexure, and stretch modes of engineered tissue conditioning investigations can be readily accomplished with the inclusion of this device in experimental protocols on engineered heart valve tissue formation.


1993 ◽  
Vol 22 (2) ◽  
pp. 113-117
Author(s):  
Noboru MURATA ◽  
Masato KUME ◽  
Satoshi KOBAYASHI ◽  
Koji MORIYASU ◽  
Hideo YOKOKAWA ◽  
...  

1999 ◽  
Author(s):  
Xiao Gong ◽  
Yi-Ren Woo ◽  
Ajit P. Yoganathan ◽  
Andreas Anayiotos

Abstract Prosthetic heart valve is one of the most successful implantable medical devices. However, introducing better performing and longer lasting prosthetic mechanical heart valves (MHV) into clinical use has been slow because predicting the long term performance of a new valve design is difficult. Although significant progresses in many scientific fronts relevant to prosthetic heart valve development have been achieved, we still have an imperfect understanding of host responses to an implantable medical device and incomplete knowledge in associating hemodynamic characteristics of a valve design to clinical performance. Valve designers, frequently need to over design the valve components to ensure structural safety and thus, sacrifice the opportunity to optimize performance. Complications such as infection, thrombus formation, thromboembolic incidents, and hemorrhage associated to the use of prosthetic valves are still reported and valve designers are working hard to eliminate them. Further advancing scientific knowledge in designing and evaluating prosthetic heart valves is of great interest to many Valve designers and manufacturers. Interfacing Industry and Academic research efforts has been thwarted due to predominantly proprietary issues. Considering the benefits of a better performing MHV to the patients, this industry session will bring researchers from various MHV companies and academic institutions to discuss how to share the results of scientific studies more effectively. This will help accelerate new MHV development without compromising the confidentiality of key valve design information. The issue of standardized MHV testing will also be addressed.


Sign in / Sign up

Export Citation Format

Share Document